Remove Compounding Remove Download Remove Immunity
article thumbnail

Flu Vaccines Are a Go

Pharmacy Times

That was the question on the minds of a lot of health care professionals, public policy leaders, public health officials, and select politicians going into the first meeting of the new Advisory Committee on Immunization Practices (ACIP) in June 2025.

article thumbnail

From Pharmacy Counters to Classrooms: Building Confidence in Back-to-School Vaccinations

Pharmacy Times

Parental vaccine hesitancy, fueled by misinformation and logistical barriers, contributes to lower immunization rates and increased exemption rates. Collaborative programs between public health departments, schools, and pharmacies aim to streamline vaccine access and improve immunization coverage.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Few Key Points Can Guide SGLT2 Inhibitor Management

Pharmacy Times

Accessed June 18, 2025.

article thumbnail

Leveraging Pharmacy Expertise and Data Systems to Meet EOM Benchmarks

Pharmacy Times

With intentional planning and system-wide support, pharmacy services can be fully integrated into EOM frameworks, ensuring their impact is recognized, measured, and rewarded.

article thumbnail

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Pharmacy Times

Further, the incidence, severity, and kinetics of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome with CD20 × CD3 TCEs may vary depending on the B-cell lymphoma subtype and the combination partners used, which is a notable consideration for oncology pharmacists when operationalizing these therapies.

article thumbnail

Pharmacists Bridge the Gaps in Care Transitions

Pharmacy Times

Centers for Medicare & Medicaid Services. Updated September 10, 2024. Accessed July 7, 2025.[link]

article thumbnail

FDA Moving to Nonanimal Testing Methodologies in Preclinical Research

Pharmacy Times

Historically, the FDA has required preclinical testing in animals to obtain safety and efficacy data for investigational new drugs (INDs) before they can begin clinical testing in humans. 3 More simply, the FDA is moving preclinical testing from in vivo animal models to in silico and in vitro methods.